Helius Medical Technologies Inc. (NASDAQ:HSDT) went down by -4.55% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Medical Devices giant went up by $0.42 to trade ended Wednesday trading at $0.44. This is down from the $0.442 price recorded on Tuesday’s trading session. Its performance from the start of the year has also been negative, with HSDT down by -56.51% year-to-date.
Helius Medical Technologies Inc. (HSDT) started the day trading at $0.44 and recorded an intraday high of $0.4499. It also recorded an intraday low of $0.41 during Wednesday’s trading session. Helius Medical Technologies Inc. is a very active stock that recorded a trading volume that is less than -70.04% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 723371, which is less than -70.04 of the total average daily trading volume of 1.23 million.
Helius Medical Technologies Inc. (NASDAQ:HSDT) 2020 Performance Impressive
The increase in HSDT’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of HSDT currently stands at $2.71, which is higher than the current trading price of the stock by 84.5%. However, HSDT’s current trading price is -68.0% lower than the 52-week low price of $0.25. In terms of trading volume, Helius Medical Technologies Inc. currently experienced healthy participation during the last trading session. 723371 shares of Helius Medical Technologies Inc. were traded on the stock exchange on Wednesday, which is less than -70.04% of the 1.23 million average trading volume of the stock.
The performance of the stock has been positive over the past year. HSDT’s performance over the past one year has seen it plunge by -83.39%, while the stock has gone down by -31.91% in the last six months. The quarterly performance of HSDT currently stands at 36.45%, and it is down by -24.66% in the last month. The only negative figure was from the weekly performance, which currently reads -13.01%. At the time of writing HSDT’s report, the company has a total market cap of $17.55M, making it one of the largest publicly-traded companies in the world.Helius Medical Technologies Inc. also has over 19 employees all over the world.
HSDT Insider Activities
For Helius Medical Technologies Inc., insiders hold 19.80% of all company shares. The insider transactions over the past six months are up by 8.20%. During that period, insiders bought 666,212 shares in 33 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Helius Medical Technologies Inc. now hold 7.62M shares, which is over 26.57% of the total company stocks. Institutional investors currently hold a large chunk of the HSDT shares, as they control 20.02% of the company’s total stock.
HSDT Fundamental Analysis
For Helius Medical Technologies Inc., the stock’s diluted earnings per share (EPS) stands at -0.57. In the coming year, analysts expect the EPS to be -0.49. The stock’s EPS growth this year is 70.50%, 15.50% in the previous five years. In terms of revenue, Helius Medical Technologies Inc.’s quarterly sales (YOY) is shrinking at -0.12, which is lower than the average annual revenue of 15.50% over the past half a decade.
The Return on Investment (ROI) on Helius Medical Technologies Inc.’s stock currently stands at -413.70%. The gross margin of the company is 30.90%.
HSDT Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of HSDT currently stands at -17.79%, while the SMA50 is -9.29%. The biggest one is the SMA200, which is currently reading -50.52% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 43.46.
